Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-03-28
1977-07-05
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 232306, 424 12, G01N 3300, G01N 3316
Patent
active
040340732
ABSTRACT:
Immunochemical composites consisting of saturating amounts of radio-labelled triiodothyronine (T.sub.3) or thyroxine (T.sub.4) complexed respectively to anti-T.sub.3 or anti-T.sub.4 antisera covalently coupled to suspendable porous glass particles via an intermediate silane coupling agent. The composites are pre-loaded into individual tubes used in solid phase radioimmunoassay of T.sub.3 or T.sub.4, requiring the addition of only test serum or standard, thereby minimizing chances of erroneous assay.
REFERENCES:
patent: 3519538 (1970-07-01), Messing et al.
patent: 3646346 (1972-02-01), Catt
patent: 3652761 (1972-03-01), Weetall
patent: 3799740 (1974-03-01), Mincey
patent: 3904373 (1975-09-01), Harper
Weetall, Biochem. Journal, vol. 117, 1970, pp. 257-261.
Weetall, Biochimica et Biophysica Acta, vol. 212, No. 1, July 15, 1970, pp. 1-7.
Corning Glass Works
Giblin James A.
Janes Jr. Clinton S.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Composite for biased solid phase radioimmunoassay of triiodothyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composite for biased solid phase radioimmunoassay of triiodothyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composite for biased solid phase radioimmunoassay of triiodothyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-578155